Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-6795

Tracking HgbA1c from end of 2023 to 2024

XMLWordPrintable

    • Icon: Other Other
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Ashley Chambers
    • 843-483-0193
    • Coastal Wound Care
    • Hide
      Thank you for your question for CMS122v12: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%). We recognize the unique challenges and limitations of specialty clinics like yours, including managing patients with diabetes and the consequent impact on performance scores. Unfortunately, making exceptions based on clinic type is not feasible with digital measures. Please note that CMS allows reporting on six measures, and considering the challenges you've outlined, you may opt out of reporting on the HbA1c poor control measure for another more feasible measure.

      We recommend exploring alternative measures that align more closely with the nature of your clinic and patient population. Acknowledging your point, we will explore the possibility of excluding instances of patient refusal in the measure calculation in a future iteration of the measure. For further information on eCQM specifications, please refer to the eCQI resource center at https://ecqi.healthit.gov/ep-ec?qt-tabs_ep=0.
      Show
      Thank you for your question for CMS122v12: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%). We recognize the unique challenges and limitations of specialty clinics like yours, including managing patients with diabetes and the consequent impact on performance scores. Unfortunately, making exceptions based on clinic type is not feasible with digital measures. Please note that CMS allows reporting on six measures, and considering the challenges you've outlined, you may opt out of reporting on the HbA1c poor control measure for another more feasible measure. We recommend exploring alternative measures that align more closely with the nature of your clinic and patient population. Acknowledging your point, we will explore the possibility of excluding instances of patient refusal in the measure calculation in a future iteration of the measure. For further information on eCQM specifications, please refer to the eCQI resource center at https://ecqi.healthit.gov/ep-ec?qt-tabs_ep=0 .
    • CMS0122v12
    • CMS0996v4
    • CMS0108v11
    • Not able to fully meet measure as described by CMS's Jan 1, 2024 - Dec 31, 2024 timeline.

      We are a private wound care center and we see patients as few as 1-2 times to following them for years. Many of our patients have diabetes. When it comes to Measure 59, HbA1c poor control, we get a negative impact on our scores for patients who had their A1C drawn Oct, Nov, or Dec 2023 and we heal their wound and discharge them from us in Jan, Feb, or Mar 2024 (before the A1c is due for another redraw). This will happen at the end of the 2024 year as well. 

      There are other examples of not being able to meet this measure also:

      • Ordering an A1C, but the patient not getting it completed. 
      • Only seeing a patient with diabetes once for a wound consultation and they not having an A1C done recently. 

      Hopefully all of this is clearly stated. 

            edave Mathematica EC eCQM Team
            ashley@coastalwoundcare.com Ashley Chambers
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: